3rd Quarter - Report

TCH GROUP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S 1145, Patent Reform Act of 2007, patent issues HR 1908, Patent Reform Act of 2007, patent issues S 316, Preserve Access to Affordable Generics Act, patent settlements International Property Issues.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th)

Health Issues HCR

HR 380, S 623, Access to Life-Saving Medicine Act; Follow-on biologics; HR 3610 Food and Drug Import Safety Act of 2007; Import safety; HR 5839, Safeguard Americans Pharmaceuticals Act; S 2029, Physician's Payment Sunshine Act; Reporting periodicity, pre-emption.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 380 (110th), H.R. 3610 (110th), H.R. 5839 (110th)

Medicare/Medicaid MMM

HR 6331 Medicare Improvements for Patients and Providers Act of 2008, implementation of the Medicare Part D Program; HR 3162 Children's Health and Medicare Protection Act of 2007; S 3101 Medicare Improvements or Patients and Providers Act of 2008; Part D, Electronic Prescribing, Medicaid Pharmacy Reimbursement. S. 3118, Preserving Access to Medicare Act of 2008.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3118 (110th), H.R. 3162 (110th), H.R. 6331 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.